A soft-adherent TLC-NOSF matrix is combined with polyacrylate poly-absorbent fibres, which guarantee wound cleaning.

 

FEATURES:

• Healing properties
• Comfort and ease of use

 

BENEFITS:

• Reduction of healing time combined with cleaning (slough, exudate, debris)
• Absorption of exudate
• Management of minor bleeding wounds
• Creation and maintenance of a moist wound environment that promotes healing
• Atraumatic removal
• Respect of peri-wound skin
• Pain free removal
• Very conformable and easy to reposition
• A vapour permeable waterproof outer film with silicone adhesive on the edges

 

INDICATIONS:

UrgoStart^® Plus NA is indicated for all stages (from the desloughing stage to complete healing) of:

• Exuding wounds
• chronic wounds
  • leg ulcers
  • pressure injuries
  • diabetic foot ulcers
• long standing acute wounds.

 

CONTRAINDICATIONS:

• UrgoStart® Plus NA facilitates the management of minor bleeding wounds. However it should not be used for heavily bleeding wounds.
• In order not to delay any optimal treatment, UrgoStart® Plus NA is contra-indicated in cancerous wounds and wounds which may reveal a deep abscess.
• Do not use when there is a known sensitivity to UrgoStart® Plus NA.

 

PRECAUTIONS:

• The soft-adherent layer of UrgoStart® Plus NA adheres to latex surgical gloves. Therefore it is recommended that the tabs be used to facilitate application of the dressing.
• As it includes a super-absorbent layer, UrgoStart® Plus NA should not be cut.
• If the wound shows signs of local infection, it is recommended that anti-microbial treatment is used first before starting treatment with UrgoStart® Plus NA.
• If an atypical ulcer presents induration or over-granulation, treatment with UrgoStart® Plus NA should only be initiated after verifying that ulcer deterioration is absent, to prevent any delay in diagnosis.
• In the absence of clinical data regarding Epidermolysis Bullosa (even for longstanding lesions), the use of UrgoStart® Plus NA is not recommended.
• Stinging or even painful sensations may be reported at the start of the treatment. These are usually linked to the healing process and the need to suspend treatment is rare.
• During desloughing, the wound may appear to get larger due to the gradual elimination of slough.
• Concomitant use with a cream, an ointment, an emulsion is not recommended.
• UrgoStart® Plus NA must not be used in a hyperbaric chamber.
• Sterile individual packaging, for single use only: re-using a disposable dressing can lead to the risks of infection.
  • Do not re-sterilise the dressing.
  • (*) Check that the sterile protector is intact before use. Do not use if package is damaged.

 

 

Product Code	Description
100440	Urgostart Plus NA Lipido-Colloid Sucrose-Octasulfate Polyfibrous Dressing 6cm x 6cm
100441	Urgostart Plus NA Lipido-Colloid Sucrose-Octasulfate Polyfibrous Dressing 10cm x 10cm
100442	Urgostart Plus NA Lipido-Colloid Sucrose-Octasulfate Polyfibrous Dressing 15cm x 20cm